🇺🇸 FDA
Pipeline program

Ponsegromab (PF-06946860), Placebo for ponsegromab (pf-06946860) solution for injection

C3651011

Phase 2 small_molecule active

Quick answer

Ponsegromab (PF-06946860), Placebo for ponsegromab (pf-06946860) solution for injection for Heart failure is a Phase 2 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
Heart failure
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials